Aclaris Therapeutics Inc.

NASDAQ: ACRS · Real-Time Price · USD
1.88
0.19 (11.24%)
At close: Aug 15, 2025, 3:59 PM
1.83
-2.40%
After-hours: Aug 15, 2025, 07:57 PM EDT

Aclaris Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-132.06M -88.48M -86.91M -90.86M
Depreciation & Amortization
807K 863K 797K 923K
Stock-Based Compensation
10.86M 20.54M 15.04M 14.06M
Other Working Capital
15.13M 10.68M -1.7M -5.15M
Other Non-Cash Items
89.41M -20.27M 4.7M 24.34M
Deferred Income Tax
n/a -367K n/a 752K
Change in Working Capital
10.92M 9.39M -1.2M -1.34M
Operating Cash Flow
-20.07M -78.33M -67.57M -52.13M
Capital Expenditures
-121K -1.31M -605K -308K
Cash Acquisitions
n/a n/a -13.23M 167.32M
Purchase of Investments
-119.98M -135.68M -164.75M -235.15M
Sales Maturities Of Investments
86.14M 183.2M 177.99M 67.83M
Other Investing Acitivies
-35.81M n/a 13.23M -167.32M
Investing Cash Flow
-69.77M 46.22M 12.63M -167.63M
Debt Repayment
n/a n/a n/a -11.48M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-377K -8K 123K -1.67M
Financial Cash Flow
74.54M 26.71M 72.87M 225.05M
Net Cash Flow
-15.31M -5.4M 17.93M 5.29M
Free Cash Flow
-20.2M -79.63M -68.17M -52.44M